Cochlear, the global leader in implantable hearing solutions, today launched the Cochlear™ Nucleus® Nexa® System – the ...

LONE TREE, Colo., July 8, 2025 /PRNewswire/ -- Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, today announced the U.S Food and Drug Administration (FDA) approval of ...

The new Osia® System with Osia OSI300 Implant enables patients to undergo MRI at 3.0 Tesla (T) without the need for surgery This has been made possible by the OSI300's unique Piezo Power™ technology ...

The Cochlear Nucleus Nexa, the world’s first smart cochlear implant system powered by the NEXOS™️ chipset, is designed to ...

Six months after becoming the first patient in the United States to receive a newly FDA-approved cochlear implant system, ...

Hearing is one of those things most people never think about until it's gone. For millions living with severe to profound ...

WHITE BEAR LAKE, MN - Envoy Medical (TASE:PMCN)®, Inc. (NASDAQ: COCH), a small-cap medical device company with a market capitalization of $29.4 million specializing in hearing loss solutions, has ...

LONE TREE, Colo., Jan. 8, 2026 /PRNewswire/ -- Cochlear, the global leader in implantable hearing solutions, is proud to announce that the groundbreaking Nucleus® Nexa® System is now available to ...

Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearing solutions, today announced the issuance of three new patents with one ...

Cochlear™ is proud to announce FDA approval for the Cochlear Nucleus® Hybrid Implant System. The system is a groundbreaking advancement that will change the way hearing loss is treated in the United ...

In celebration of International Cochlear Implant Day, Cochlear North America is proud to announce the recipients of the 2026 Cochlear Academic Scholarships. This year, eight exceptional students, who ...